text: <unk> (tablet) is a platelet aggregation inhibitor that is FDA approved for the treatment of postoperative thromboembolic complications of cardiac valve replacement.   Common adverse reactions include chest pain, electrocardiogram abnormalities, flushing, rash, abdominal discomfort, dizziness, headache, and dyspnea.
option_0: Dipyridamole 
option_1: Temocapril
option_2: Gadoxetate
option_3: Boldenone
option_4: Colestilan
option_5: Cetrorelix
option_6: Ticlopidine
option_7: Ramipril